CSIMarket
 

Inotiv Inc   (NASDAQ: NOTV)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Inotiv Inc 's

Competitiveness




 

NOTV Sales vs. its Competitors Q2 2026



Comparing the current results to its competitors, Inotiv Inc reported Revenue decrease in the 2 quarter 2026 year on year by -5.37 %, despite the revenue increase by the most of its competitors of 7.55 %, recorded in the same quarter.

List of NOTV Competitors





Revenue Growth Comparisons




Net Income Comparison


Inotiv Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 7.15 %

<<  NOTV Stock Performance Comparisons



  

Overall company Market Share Q2 2026

Overall company, revenue fell by -5.37 % and company lost market share, to approximately 1.24 %.




<<  More on NOTV Market Share.
 
*Market share is calculated based on total revenue.

  News about Inotiv Inc Contracts

Inotiv Resolves Cumberland Facility Probe, Reinforces Animal Welfare Commitment

June 3, 2024
Inotiv, a prominent contract research organization, announced an agreement with regulatory authorities to resolve the previously disclosed investigation concerning its shuttered Cumberland, Virginia facility. The investigation focused on allegations related to non-compliance with animal welfare standards at the facility, which led to its closure.The company, headquartered in West Lafayette, Indiana, reiterated its commitment to upholding the highest standards of animal welfare and compliance. Inotiv clarified that they have been actively cooperating with the investigation and have worked closely with regulatory bodies to address any concerns raised. Investigative Background:- In May 2022, the investigation i...





Publicly Traded Peers of Inotiv Inc




Iqvia Holdings Inc
Share Performance



+0.52%
Over The Past 5 Days



Iqvia Holdings Inc
Profile

IQVIA Holdings Inc operates a multifaceted business model that focuses on delivering advanced analytics, technology solutions, and clinical research services tailored for the healthcare sector. By harnessing extensive data resources and industry expertise, the company aids clients in optimizing operations, enhancing drug development processes, and ultimately improving patient outcomes.

More about Iqvia Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 44,277.048 mill. $ 16,632.000 mill. $ 1,387.000 mill.


Medpace Holdings Inc
Share Performance



+30.91%
This Quarter



Medpace Holdings Inc
Profile

Medpace Holdings Inc is a contract research organization (CRO) that provides various services in the clinical research and development of drugs and medical devices.

More about Medpace Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 16,712.656 mill. $ 2,782.288 mill. $ 491.500 mill.


Charles River Laboratories International inc
Share Performance



+42.40%
This Year



Charles River Laboratories International inc
Profile

Charles River Laboratories International Inc is a contract research organization (CRO) that provides essential services and support to the pharmaceutical, biotech, and medical device industries. They offer a wide range of research models, drug discovery and development services, safety assessments, and laboratory animal medicine to assist in the preclinical and clinical stages of drug development.

More about Charles River Laboratories International inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 14,110.126 mill. $ 4,027.044 mill. $ -182.843 mill.


Labcorp Holdings Inc
Share Performance



+30.99%
This Year



Labcorp Holdings Inc
Profile

Labcorp Holdings Inc operates as a major healthcare diagnostics company, providing clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model emphasizes delivering accurate and timely test results to aid in patient diagnosis, treatment, and monitoring.

More about Labcorp Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 27,328.814 mill. $ 14,144.200 mill. $ 942.700 mill.

Sources: Inotiv Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Inotiv Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.